Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
85 participants
INTERVENTIONAL
2025-03-20
2025-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Postoperative Analgesic Efficacy of SPSIPB and ISBPB
NCT06626191
Comparison of Postoperative Analgesic Efficacy of SPSIPB and Combination of IBPB and SCPB
NCT06660875
Interscalene Block vs Serratus Posterior Superior Intercostal Plane Block
NCT07278050
Postoperative Pain in Shoulder Surgery
NCT06265571
Comparison of the Analgesic Effects of Continuous Versus Single-Shot Serratus Posterior Superior Intercostal Plane Block in Arthroscopic Shoulder Surgery
NCT06826846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intraplexus approach in interscalene block
The block needle will be advanced from the middle scalene muscle in a posterior-anterior direction and advanced between the C5-C6 nerve roots and the injection will be performed
Intraplexus
The block needle will be advanced from the middle scalene muscle in a posterior-anterior direction and advanced between the C5-C6 nerve roots and the injection will be performed
Extraplexus approach in interscalene block
The block needle will first be advanced above the C5 nerve root and towards the anterior part of the brachial plexus and 10 ml of local anesthetic will be injected. Then, the needle will be withdrawn to the posterior surface of the brachial plexus and 10 ml of local anesthetic will be administered.
Extraplexus
The block needle will first be advanced above the C5 nerve root and towards the anterior part of the brachial plexus and 10 ml of local anesthetic will be injected. Then, the needle will be withdrawn to the posterior surface of the brachial plexus and 10 ml of local anesthetic will be administered.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraplexus
The block needle will be advanced from the middle scalene muscle in a posterior-anterior direction and advanced between the C5-C6 nerve roots and the injection will be performed
Extraplexus
The block needle will first be advanced above the C5 nerve root and towards the anterior part of the brachial plexus and 10 ml of local anesthetic will be injected. Then, the needle will be withdrawn to the posterior surface of the brachial plexus and 10 ml of local anesthetic will be administered.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with ASA physical status I or II.
* Patients planned for arthroscopic shoulder surgery in the lateral decubitus position with interscalene nerve block.
Exclusion Criteria
* Block failure.
* Language acquisition deficiency.
* Obesity (body mass index \> 35 kg/m²).
* Diabetes.
* Psychiatric disorders.
* Central nervous system diseases.
* Vestibular diseases.
* Presence of neuropathy and paralysis.
* Pregnancy.
* Previous open shoulder surgery.
* Allergy to local anesthetics.
* Coagulopathy.
* Severe thrombocytopenia.
* Infection at the puncture site.
* Pre-existing neuropathy in the limb to be operated.
* Use of dexamethasone.
* Use of opioid and antiemetic medications before surgery.
* Severe cardiopulmonary disease.
* Low baseline oxygen saturation.
* Conditions that prevent cooperation in the postoperative period (e.g., mental retardation, delirium).
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gökhan Erdem
Anesthesiology and Reanimation specialist doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Bilkent City Hospital
Ankara, Ankara, Çankaya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rebound pain
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.